Sign in

CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
operating
EIN
223542636
Phone
2017502646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
  1. 4 Grant or award Chairman, CEO, President acquired 2,854,279 shares (grant or award)
  2. 4 Grant or award Director acquired 81,549 shares (grant or award)
  3. 4 Grant or award CFO, Sec., Treas acquired 122,325 shares (grant or award)
  4. 4 Grant or award Director acquired 81,549 shares (grant or award)
  5. 4 Grant or award Director acquired 81,549 shares (grant or award)
  6. 4 Other acquisition President & CEO acquired 113,954 shares (other)
  7. 4 Gift Director gave 6,000,000 shares (gift)
  8. 4 Open-market sale Chairman of Board sold 150,000 shares at an average $0.30 ($45,253)
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award 10% owner acquired 54,169 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Conversion President & CEO acquired 2,741,801 shares (conversion)
  13. 4 Conversion Director acquired 2,000,000 shares (conversion)
  14. 4/A Other acquisition Director acquired 19,275,135 shares (other)
  15. 4/A Open-market sale Director sold 157,012 shares at $0.41 ($64,626)
  16. 4/A Other acquisition Director acquired 19,275,135 shares (other)
  17. 4 Conversion Director acquired 2,000,000 shares (conversion)
  18. 4/A Derivatives Options or other derivatives
  19. 4/A Derivatives Options or other derivatives
  20. 4 Open-market sale Executive VP of Operations sold 85,530 shares at $0.24 ($20,168)

Page 4 of 26 · 511 filings